# Agentic Proving for Program Verification

Preprint · Alessandro Sosso, Akhil Arora, Bas Spitters

- Archive id: arxiv:2605.23772
- Published: 2026-05-22
- arXiv: https://arxiv.org/abs/2605.23772
- Source URL: https://arxiv.org/abs/2605.23772
- PDF: https://arxiv.org/pdf/2605.23772
- Provenance: arxiv

## Abstract

Agentic systems have recently emerged as state-of-the-art approaches for automated theorem proving in formal mathematics. To assess how far these capabilities extend to program verification, we evaluate Claude Code in an agentic proving framework on CLEVER, a Lean 4 benchmark for verifiable code generation. Our results show that Claude generates arguably valid specifications for 98.8% of problems (with 81.3% also accepted by CLEVER's isomorphism-based scoring on the correct portion of the benchmark), certifies implementations against correct ground-truth specifications for 87.5% of problems, and reaches a 98.1% success rate on the end-to-end program generation and verification pipeline over entries with self-consistent premises. Across all stages, Claude further provides high-quality feedback on its own attempts (as confirmed under manual review), identifying underlying causes of failure and lingering bugs in the dataset. These findings highlight a growing mismatch between the difficulty of existing program verification benchmarks and the capabilities of modern agentic provers, and point to the need for more rigorous, bug-resilient evaluation methodologies, and in particular for alternatives to isomorphism-based scoring of generated specifications. More broadly, our results provide empirical evidence that tight compiler-in-the-loop agentic paradigms are currently the most effective approach for foundational program verification.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
